Compare HROW & CXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HROW | CXM |
|---|---|---|
| Founded | 1998 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2008 | 2021 |
| Metric | HROW | CXM |
|---|---|---|
| Price | $39.48 | $6.70 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 8 |
| Target Price | ★ $69.86 | $8.28 |
| AVG Volume (30 Days) | 550.4K | ★ 2.6M |
| Earning Date | 05-11-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.43 | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $857,200,000.00 |
| Revenue This Year | $31.62 | $2.52 |
| Revenue Next Year | $50.77 | $4.94 |
| P/E Ratio | ★ N/A | $344.50 |
| Revenue Growth | N/A | ★ 7.64 |
| 52 Week Low | $28.54 | $4.72 |
| 52 Week High | $54.98 | $8.85 |
| Indicator | HROW | CXM |
|---|---|---|
| Relative Strength Index (RSI) | 49.09 | 64.16 |
| Support Level | $37.03 | $5.25 |
| Resistance Level | $41.82 | $7.62 |
| Average True Range (ATR) | 1.80 | 0.24 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 49.15 | 68.12 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale, all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights, and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.